<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/001A9792-C636-4B75-A8D4-A3C1B55359DC"><gtr:id>001A9792-C636-4B75-A8D4-A3C1B55359DC</gtr:id><gtr:firstName>Ashok</gtr:firstName><gtr:surname>Venkitaraman</gtr:surname><gtr:orcidId>0000-0002-6876-2672</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UU_12022%2F1"><gtr:id>1FE46DD2-3212-4B40-9B73-7A1318C2C53B</gtr:id><gtr:title>Chromosomal instability in cancer pathogenesis and treatment</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UU_12022/1</gtr:grantReference><gtr:abstractText>The genetic material within cancer cells is highly unstable. The overall purpose of our work is to understand how this instability contributes to cancer growth, and to use this new knowledge to better pinpoint genetic risks for human cancer, and to develop new approaches for cancer detection and therapy. In particular, we will study pancreatic cancer, a leading cause of death, for which there is an urgent unmet medical need to improve detection and therapy.</gtr:abstractText><gtr:technicalSummary>Instability in the structure and number of chromosomes is a hallmark of human epithelial cancers. It is triggered during the poorly understood transition from pre-invasive to cancerous lesions early in carcinogenesis. What provokes genome instability, and how it fosters cancer pathogenesis, remain major unresolved questions central to understanding early steps in the evolution of cancer. How human genetic variations affecting the maintenance of genome stability may foster cancer risk, and how the near-universal occurrence of genome instability in common epithelial malignancies may be exploited in new approaches to cancer therapy, remain to be explored. We aim to understand how the mechanisms that engender genome instability contribute to early steps in epithelial carcinogenesis. We will exploit this knowledge to better stratify the genetic risks underlying human cancer predisposition, and to develop new approaches for cancer detection and therapy that can be applied in the clinic.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-10-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>2949000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Participation in MRC Festival of Science Open Day 2016 at MRC CU</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>1F0B0581-C37A-4ADB-88E1-7C564E144B66</gtr:id><gtr:impact>60 sixth-form students from across 8 schools in Cambridge visited the MRC Cancer Unit on the afternoon of the 22nd of June, 2016 for an Open Day. All students, accompanied by their teachers, were given a tour of the enitre building with an opportunity for engaging with researchers about the state of the art in cancer research and gaining hands-on experience with setting up experiments. Talks about career opportunities and challenges associated with pursuing cancer research were also available to all attendees. The event sparked a great deal of interest and enthusiasm in students and teachers alike and we have had a request for this event to be continued. We will be pursuing a similar format of activities for the MRC Science Festival in 2017, but reach out to more number of schools, including those outside of Cambridge city perimeters.</gtr:impact><gtr:outcomeId>58ad9cceba6157.11382164</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>https://mrccancerunit.wordpress.com/2016/07/06/inspiring-the-next-generation-of-cancer-researchers-the-mrc-cancer-unit-open-day-2016/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Hosted week long lab-experience visit from Sixth Form students in 2016</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>8D3DD059-E21C-4444-89F9-91CD61A7C6F8</gtr:id><gtr:impact>A lab-experience tour for a week was organised at the Venkitaraman labs for students from the Hills Road Sixth Form College, Cambridge. During this visit, 6 students interacted with researchers from the Venkitaraman group, were given supervised exposure to laboratory techniques and Professor Venkitraman gave them an overview lecuture at the beginning of their visit. The students very appreciative of the whole experience and communicated their views through a post that is now hosted on the MRC CU blogsite. Very positive feedback was also received from the Head of Biology at the School about this experience, with a request for continuation of such visits to the Unit in the coming years.</gtr:impact><gtr:outcomeId>58adb652d47d11.77904881</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>https://mrccancerunit.wordpress.com/2016/11/29/of-inspiring-fresh-minds-of-fresh-new-ways-of-looking-at-cancer/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Featured article in MRC Research Horizons</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>780469F2-40BC-40CC-BA1F-8A2756BD2663</gtr:id><gtr:impact>Article for MRC Research Horizons magazine on the incidence and treatment of TB in India. Promoted the Center for Chemical Biology and Therapeutics (CCBT) in India and created awareness of similar types of novel drug targets that have been implicated in infectious diseases, cancer and even developmental defects.</gtr:impact><gtr:outcomeId>56ab9aec549635.21396156</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Third sector organisations</gtr:primaryAudience><gtr:url>https://www.cam.ac.uk/system/files/issue_28_research_horizons.pdf</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Speaker at the Cambridge Science festival</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DB5E0B54-73C5-4E2A-B7F8-352DF6E7670B</gtr:id><gtr:impact>Delivered a lecture about the recent scientific advances that promise to transform our ability to translate biological knowledge into new medicines. The talk, although heavily charged with information about the state of the art advances in the field of cancer research and medicine development, was tailored to provide clarity about these complex issues to the general audience and was very well received by all attending.</gtr:impact><gtr:outcomeId>58ada1124b74c8.90657736</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.sciencefestival.cam.ac.uk/events?search_api_views_fulltext=cancer</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Festival 2014</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>8395A7C4-C63F-4485-A491-07E0355AAF63</gtr:id><gtr:impact>Group members spoke about their research and coordinated activities for the public such as DNA extraction.

Increased awareness of cancer research and its importance.</gtr:impact><gtr:outcomeId>543e4b6144e7a6.48076089</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview on BBC Radio Cambridgeshire</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>F86E38DF-03C7-49C2-8080-92B34A9ED244</gtr:id><gtr:impact>Interview on local radion Drivetime programme to discuss cancer research and promote cambridge science festival activities

Increased awareness of research and attendance at festival event</gtr:impact><gtr:outcomeId>543e4c4c6a6237.42995797</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Research Group's participation in Cambridge University Science Festival (2015-2016)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EC9A4DC9-1243-4B17-9E41-63EAF9919EA1</gtr:id><gtr:impact>The Cambridge Science Festival aims to reach out to the general public and communicate about the different aspects of science and research being undertaken at the University. It is a free event, over two weeks, with an excess of 270 events and more than 30000 attendees. As part of this, the MRC CU along with the CRUK CI organised a set of talks and activities that were attended by over 100 people from all walks of life - from young children and young adults to parents/carers and professionals. The Venkitaraman lab was part of the MRC CU team at these events. The event generated a lot of interest in cancer research, helped raise awareness about the importance of 'early' in cancer which is the mission of the MRC CU and also led to a lot of interest being generated in the MRC Festival of Science which followed on later in the summer of 2016.</gtr:impact><gtr:outcomeId>58ad9f08c5a612.03055760</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.sciencefestival.cam.ac.uk/events?search_api_views_fulltext=cancer</gtr:url><gtr:year>2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Festival Speaker Spotlight</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7C3B235A-6194-479C-8355-B758B640D0F1</gtr:id><gtr:impact>Interviewed for Cambridge Science Festival Speaker Spotlight

Increased awareness of cancer research and festival activities.</gtr:impact><gtr:outcomeId>543e4bd25c3199.20444292</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.cam.ac.uk/science-festival/news-media/speaker-spotlights/speaker-spotlight-professor-ashok-venkitaraman</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>76462</gtr:amountPounds><gtr:country>Unknown</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhoreMost</gtr:description><gtr:end>2016-02-02</gtr:end><gtr:fundingOrg>PhoreMost</gtr:fundingOrg><gtr:id>00A9E803-127B-443C-8517-960E51C9B0C0</gtr:id><gtr:outcomeId>56d5c0ff328607.79387338</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>39916</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Parsotix Team</gtr:department><gtr:description>ParSortix - staff funding</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>ANGLE</gtr:fundingOrg><gtr:id>180B8362-7E8E-499D-B13F-CAD44B40B7B4</gtr:id><gtr:outcomeId>545cb9ea234424.44351913</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1151979</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC - A Joint Centre for Cancer Biology &amp;amp; Therapeutics (fellowships)</gtr:description><gtr:end>2018-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/N501876/1</gtr:fundingRef><gtr:id>F430C0E9-4682-483F-A854-33D5117E5DBD</gtr:id><gtr:outcomeId>56d5c2f171ed54.21343074</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Steering committee member of The National Centres of Competence in Research NCCR of the Swiss National Science Foundation (SNSF)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>C407111B-0FFD-4566-BE6E-C93416BDAB1B</gtr:id><gtr:impact>As part of the steering committee influenced the scientific drection and policy impact of this organisation</gtr:impact><gtr:outcomeId>58ad9adabb2490.56249885</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Governing Council member of INSTITUTE FOR STEM CELL BIOLOGY AND REGENERATIVE MEDICINE, Bangalore, India</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>958552F3-E519-4BC7-A452-773690333E29</gtr:id><gtr:impact>As a member of the Governing council of this world renowned research Institute, have contributed to steering the direction and progress of fundamental research and training at the institute.</gtr:impact><gtr:outcomeId>58ad968f3ee6b3.53430019</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Steering committee member of The Early Detection Programme of the Cambridge Cance Centre</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C09D7713-6133-4946-AB54-E0549646111E</gtr:id><gtr:impact>As part of the steering committee influenced the direction of research and training offered by this organisation</gtr:impact><gtr:outcomeId>58ad9bca5fa887.44427382</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>81B8CCBE-3602-4AD6-8957-C09A7387AC86</gtr:id><gtr:title>Micro(mi) RNA-34a targets protein phosphatase (PP)1? to regulate DNA damage tolerance.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc329042393bda9d8373ce4d6b137310"><gtr:id>cc329042393bda9d8373ce4d6b137310</gtr:id><gtr:otherNames>Takeda Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>560cf485a20e24.00359131</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27557D81-D9B0-4011-A36D-D905900BAC22</gtr:id><gtr:title>Linear aliphatic dialkynes as alternative linkers for double-click stapling of p53-derived peptides.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8586c6b180b864a824ed1eec5eb01a4"><gtr:id>a8586c6b180b864a824ed1eec5eb01a4</gtr:id><gtr:otherNames>Lau YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn><gtr:outcomeId>545e5a98179cc7.81091990</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>243EEE1F-341A-4AD6-8354-6EEDE6BF5AB3</gtr:id><gtr:title>Small-molecule inhibitors that target protein-protein interactions in the RAD51 family of recombinases.</gtr:title><gtr:parentPublicationTitle>ChemMedChem</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/584952b12d6156f6729a395528a9a0f6"><gtr:id>584952b12d6156f6729a395528a9a0f6</gtr:id><gtr:otherNames>Scott DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1860-7179</gtr:issn><gtr:outcomeId>56e158a951dd79.34984658</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ADEDAB8D-439C-4D52-8554-75ED2CFDED13</gtr:id><gtr:title>Double Strain-Promoted Macrocyclization for the Rapid Selection of Cell-Active Stapled Peptides.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8586c6b180b864a824ed1eec5eb01a4"><gtr:id>a8586c6b180b864a824ed1eec5eb01a4</gtr:id><gtr:otherNames>Lau YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn><gtr:outcomeId>56c71930991445.77820538</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6B6DFB6-F4E4-470A-A662-A6D7A1C25213</gtr:id><gtr:title>A cancer-associated mutation inactivates a region of the high-mobility group protein HMG20b essential for cytokinesis.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52329ae785e789fb6117f1ddca3cd12b"><gtr:id>52329ae785e789fb6117f1ddca3cd12b</gtr:id><gtr:otherNames>Lee M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>545e5a97c09e68.33250350</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06C8ED6F-8CDF-4C1E-817B-80DDFB2D8620</gtr:id><gtr:title>Homeostatic control of polo-like kinase-1 engenders non-genetic heterogeneity in G2 checkpoint fidelity and timing.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24ec375abd205ba8e96b7e4e07a57e2b"><gtr:id>24ec375abd205ba8e96b7e4e07a57e2b</gtr:id><gtr:otherNames>Liang H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5436a0730c63b3.24331542</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A14DA08-955D-4EC7-9612-B86158B89862</gtr:id><gtr:title>Investigating peptide sequence variations for 'double-click' stapled p53 peptides.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8586c6b180b864a824ed1eec5eb01a4"><gtr:id>a8586c6b180b864a824ed1eec5eb01a4</gtr:id><gtr:otherNames>Lau YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>5436a0733da501.21421209</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5807C66A-8F85-4037-BA5A-B42D1C939B09</gtr:id><gtr:title>Computationally-guided optimization of small-molecule inhibitors of the Aurora A kinase-TPX2 protein-protein interaction.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74caa858e1c4622a8245ad51cfc3acbe"><gtr:id>74caa858e1c4622a8245ad51cfc3acbe</gtr:id><gtr:otherNames>Cole DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>5a35ad2e121b39.47480441</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B593913-EC31-41A3-ABD5-5B70C1B1982E</gtr:id><gtr:title>Diversity-oriented synthesis as a tool for identifying new modulators of mitosis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5966b8b69ea8c08c65551eb5584b90da"><gtr:id>5966b8b69ea8c08c65551eb5584b90da</gtr:id><gtr:otherNames>Ibbeson BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5436a0745dc985.18189042</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EB4F6D2-57D8-43A9-B1DD-85877D6F0ED0</gtr:id><gtr:title>A Class of Environmental and Endogenous Toxins Induces BRCA2 Haploinsufficiency and Genome Instability.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b366faa210eb4d0c0d06e001b09afa2"><gtr:id>5b366faa210eb4d0c0d06e001b09afa2</gtr:id><gtr:otherNames>Tan SLW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>5a361bbe8a3ed7.53046529</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71703936-9BC5-4705-96C8-7A4FA83A7045</gtr:id><gtr:title>p53 shapes genome-wide and cell type-specific changes in microRNA expression during the human DNA damage response.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7de3df12752ce5f2ad67ba8b804a0bc"><gtr:id>f7de3df12752ce5f2ad67ba8b804a0bc</gtr:id><gtr:otherNames>Hattori H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>545e5a97e8b238.79182008</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>010D847B-7FA9-4C25-8213-F81A0FD933F7</gtr:id><gtr:title>BRCA2 Regulates Transcription Elongation by RNA Polymerase II to Prevent R-Loop Accumulation.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e1b7d19e05a9a3509bade12bc491a03"><gtr:id>1e1b7d19e05a9a3509bade12bc491a03</gtr:id><gtr:otherNames>Shivji MKK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:outcomeId>5a8af96ab57b97.91084951</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BFD856C5-6A3C-4DD3-9778-1DDBFB692641</gtr:id><gtr:title>Chromosome instability and carcinogenesis: insights from murine models of human pancreatic cancer associated with BRCA2 inactivation.</gtr:title><gtr:parentPublicationTitle>Molecular oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1333dc61a50bcdc0960fd1f4abc240f"><gtr:id>d1333dc61a50bcdc0960fd1f4abc240f</gtr:id><gtr:otherNames>Cassidy LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1574-7891</gtr:issn><gtr:outcomeId>5436a074935226.20290992</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D0997B2-71CE-49D2-BA2B-79D9ABD3CA66</gtr:id><gtr:title>Allosteric modulation of AURKA kinase activity by a small-molecule inhibitor of its protein-protein interaction with TPX2.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9984bc41af77236e9cd269aa01cfc43"><gtr:id>e9984bc41af77236e9cd269aa01cfc43</gtr:id><gtr:otherNames>Janecek M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>585d54a14709f0.00635356</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E309E76-0E32-482B-9E34-7182BA63920E</gtr:id><gtr:title>Oncogenic KRAS triggers MAPK-dependent errors in mitosis and MYC-dependent sensitivity to anti-mitotic agents.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b77196dcbdac386045a7b78c93cc1468"><gtr:id>b77196dcbdac386045a7b78c93cc1468</gtr:id><gtr:otherNames>Perera D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>585d69859475d9.84005924</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF3B67DB-FC5E-404C-AFDB-48704910088F</gtr:id><gtr:title>Modulating Protein-Protein Interactions of the Mitotic Polo-like Kinases to Target Mutant KRAS.</gtr:title><gtr:parentPublicationTitle>Cell chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/187f9a328dc6313ad6bb6511540f482a"><gtr:id>187f9a328dc6313ad6bb6511540f482a</gtr:id><gtr:otherNames>Narvaez AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2451-9448</gtr:issn><gtr:outcomeId>5a2fd5b2b300e5.40269283</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BE3EC3B-C038-418A-9EC9-3BEF1DAA427C</gtr:id><gtr:title>Fast and simple spectral FLIM for biochemical and medical imaging.</gtr:title><gtr:parentPublicationTitle>Optics express</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e7112117de6a6278abb94866d1e21364"><gtr:id>e7112117de6a6278abb94866d1e21364</gtr:id><gtr:otherNames>Popleteeva M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1094-4087</gtr:issn><gtr:outcomeId>560cf485695426.64147424</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86C3CA02-6B2F-4C44-8E9D-89F83878DCD8</gtr:id><gtr:title>Contributions to drug resistance in glioblastoma derived from malignant cells in the sub-ependymal zone.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/405661fdcf6221fcaf0188903b88709e"><gtr:id>405661fdcf6221fcaf0188903b88709e</gtr:id><gtr:otherNames>Piccirillo SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>560cf4861241b4.30809774</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1FDDE99B-20B2-4D19-BB0E-42C40AF4D46C</gtr:id><gtr:title>High content screening of diverse compound libraries identifies potent modulators of tubulin dynamics.</gtr:title><gtr:parentPublicationTitle>ACS medicinal chemistry letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f5b243c4d6b98f63194d44a82af0669"><gtr:id>0f5b243c4d6b98f63194d44a82af0669</gtr:id><gtr:otherNames>Laraia L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1948-5875</gtr:issn><gtr:outcomeId>54369fff59f1d9.42388833</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E88D3E8-C518-491B-A56E-66EC987542F9</gtr:id><gtr:title>Overcoming Chemical, Biological, and Computational Challenges in the Development of Inhibitors Targeting Protein-Protein Interactions.</gtr:title><gtr:parentPublicationTitle>Chemistry &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f5b243c4d6b98f63194d44a82af0669"><gtr:id>0f5b243c4d6b98f63194d44a82af0669</gtr:id><gtr:otherNames>Laraia L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1074-5521</gtr:issn><gtr:outcomeId>560cf485d48c42.83271908</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3CD59A0-2661-4871-A6DD-99DB8B06225C</gtr:id><gtr:title>Maximizing the biochemical resolving power of fluorescence microscopy.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f542cf3e85d9fc356dcf95ba1bac77f"><gtr:id>4f542cf3e85d9fc356dcf95ba1bac77f</gtr:id><gtr:otherNames>Esposito A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5436a074bd82f0.77861645</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B23D702E-54AE-4995-A02B-0153B2BCB083</gtr:id><gtr:title>RNA Processing and Genome Stability: Cause and Consequence.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a19d29473af70d14c697b8cd9ba75e65"><gtr:id>a19d29473af70d14c697b8cd9ba75e65</gtr:id><gtr:otherNames>Wickramasinghe VO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>56d6b2a41f6f91.00301229</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08E44665-491C-4532-917D-94DF4D30066C</gtr:id><gtr:title>Single-molecule localization microscopy reveals molecular transactions during RAD51 filament assembly at cellular DNA damage sites.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab21d44b78fe23719d03571b6a3577e3"><gtr:id>ab21d44b78fe23719d03571b6a3577e3</gtr:id><gtr:otherNames>Haas KT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>5a8af2b41eacc3.79498468</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C57FF87-BD08-41E8-B56B-E51BCE9626A6</gtr:id><gtr:title>Regulation of constitutive and alternative mRNA splicing across the human transcriptome by PRPF8 is determined by 5' splice site strength.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a19d29473af70d14c697b8cd9ba75e65"><gtr:id>a19d29473af70d14c697b8cd9ba75e65</gtr:id><gtr:otherNames>Wickramasinghe VO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>560cf4852d82c6.89842347</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A98C623B-57A6-47B4-8900-FE4BF27E62B7</gtr:id><gtr:title>Selective nuclear export of specific classes of mRNA from mammalian nuclei is promoted by GANP.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a19d29473af70d14c697b8cd9ba75e65"><gtr:id>a19d29473af70d14c697b8cd9ba75e65</gtr:id><gtr:otherNames>Wickramasinghe VO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>5436a074086e53.17611449</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18151C76-B39A-43B7-9979-6C3B8992B2DD</gtr:id><gtr:title>High-resolution structure of the presynaptic RAD51 filament on single-stranded DNA by electron cryo-microscopy.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba4097716d2c886a85ad04e75c4aa8d2"><gtr:id>ba4097716d2c886a85ad04e75c4aa8d2</gtr:id><gtr:otherNames>Short JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>5806228023f215.45405734</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A017225-D868-491E-B421-FD1333FA32C8</gtr:id><gtr:title>Impact of Alternative Splicing on the Human Proteome.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7c92a675b6502a97a707b04cca69bc1"><gtr:id>d7c92a675b6502a97a707b04cca69bc1</gtr:id><gtr:otherNames>Liu Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a2fd588967543.61841113</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D52A758A-9991-4DC4-84AE-B0CA55C551AA</gtr:id><gtr:title>Cancer suppression by the chromosome custodians, BRCA1 and BRCA2.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eaeb2e81353ecad12ce5da26aad67c13"><gtr:id>eaeb2e81353ecad12ce5da26aad67c13</gtr:id><gtr:otherNames>Venkitaraman AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>5436a0736524f5.66150703</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UU_12022/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>